Literature DB >> 17464579

Screening for pre-eclampsia and small for gestational age fetuses at the 11-14 weeks scan by uterine artery Dopplers.

Athanasios Pilalis1, Athena P Souka, Panayiotis Antsaklis, Konstantinos Basayiannis, Panayiotis Benardis, Dimitrios Haidopoulos, Nikolaos Papantoniou, Spyros Mesogitis, Aris Antsaklis.   

Abstract

OBJECTIVE: To assess the role of uterine artery Doppler studies at 11-14 weeks in screening for pre-eclampsia (PET), small for gestational age (SGA) fetuses, and placental abruption.
METHODS: Prospective study on 1,123 women presenting for routine ultrasound examination at 11-14 weeks for nuchal translucency measurement. Uterine artery blood flow was studied by transvaginal colour Doppler, the mean pulsatility index (PI) was calculated, and the presence of a diastolic notch was recorded.
RESULTS: The mean, median and 95th centile of uterine artery PI were 1.71, 1.64 and 2.54, respectively. Bilateral notches were observed in 63.4%, and a unilateral notch in 18.4% of cases. The sensitivity of mean uterine artery PI>or=95th centile for PET, early onset severe PET necessitating delivery before 34 weeks, SGA<or=5th centile, SGA necessitating delivery before 34 weeks, SGA<or=10th centile and placental abruption were 21.4, 33.3, 17.8, 100, 9.6 and 44.4%, respectively. One in 6 women with increased resistance in the uterine arteries at 11-14 weeks will develop a complication related to utero-placental insufficiency.
CONCLUSIONS: Abnormal uterine Dopplers at 11-14 weeks identified one-third of women with severe early onset pre-eclampsia, all fetuses with SGA<or=5th centile that were delivered at<or=34 weeks, and 40% of cases with placental abruption. Uterine artery Doppler examination at the 11-14 weeks scan can identify a high risk population in which preventive or therapeutic interventions might be effective.

Entities:  

Mesh:

Year:  2007        PMID: 17464579     DOI: 10.1080/00016340601155056

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  Predictive values of maternal serum PAPP-A level, uterine artery Doppler velocimetry, and fetal biometric measurements for poor pregnancy and poor neonatal outcomes in pregnant women.

Authors:  Serdar Balcı
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-09-01

2.  A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Samuel S Edwin; Ricardo Gomez; Lami Yeo; Agustin Conde-Agudelo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

3.  Placental oxygen transport estimated by the hyperoxic placental BOLD MRI response.

Authors:  Anne Sørensen; Marianne Sinding; David A Peters; Astrid Petersen; Jens B Frøkjær; Ole B Christiansen; Niels Uldbjerg
Journal:  Physiol Rep       Date:  2015-10

4.  Uterine artery pulsatility index in hypertensive pregnancies: When does the index normalize in the puerperium?

Authors:  Seung Mi Lee; Jong Kwan Jun; Su Jin Sung; Sung Il Choo; Jeong Yeon Cho; Hye Jin Yang; Chan-Wook Park; Joong Shin Park; Hee Chul Syn
Journal:  Obstet Gynecol Sci       Date:  2016-11-15

5.  Diagnostic Performance of First Trimester Screening of Preeclampsia Based on Uterine Artery Pulsatility Index and Maternal Risk Factors in Routine Clinical Use.

Authors:  Max Mönckeberg; Valentina Arias; Rosario Fuenzalida; Santiago Álvarez; Victoria Toro; Andrés Calvo; Juan P Kusanovic; Lara J Monteiro; Manuel Schepeler; Jyh K Nien; Jaime Martinez; Sebastián E Illanes
Journal:  Diagnostics (Basel)       Date:  2020-03-26

Review 6.  Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.

Authors:  Sarosh Rana; Suzanne D Burke; S Ananth Karumanchi
Journal:  Am J Obstet Gynecol       Date:  2020-10-20       Impact factor: 8.661

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.